The lawyers at Saiontz & Kirk, P.A. are reviewing potential Roundup cancer lawsuits against Monsanto, for failing to adequately research the human health risks associated with their popular weedkiller and for withholding important warnings from consumers and the agricultural industry.

Roundup WeedkillerAs these cases for non-Hodgkins lymphoma and other cancers from Roundup are being investigated, it has become increasingly clear that Monsanto has known for years, or certainly should have known, that the chemical glyphosate contained in Roundup may increase the risk of cancer and cause serious human health side effects.

Media attention on the link between Roundup and cancer emerged early last year, when the World Health Organization (WHO) categorized glyphosate as a probable human carcinogen. However, substantial evidence existed long before these cancer warnings, which Monsanto either chose to ignore or actively withheld from the public.

The following timeline shows how far back concerns over glyphosate health effects have been raised:

1974 — Monsanto puts Roundup weed killer on the market.

1976 — The FDA inspects Industrial Bio-Test Industries (IBT) and raises questions about the validity of the independent lab’s toxicity tests of glyphosate. The EPA follows up and found the Roundup toxicity studies to be invalid and found “routine falsification of data.”

1983 — Three top IBT executives are convicted of fraud.

1985 — The EPA classifies glyphosate as “possibly carcinogenic to humans.”

1991 — The EPA changes the classification to ‘evidence of non-carcinogenicity in humans” but cautions that does not mean glyphosate does not cause cancer.

1991 — A second independent lab, Craven Laboratories is hired by Monsanto to test glyphosate. Later that year, the owner and several employees are indicted and later convicted of falsifying data for pesticide and herbicide studies.

1995 — EPA releases a glyphosate technical fact sheet warning that there is widespread exposure to glyphosate and that it could cause congestion of the lungs, increased breathing rate, kidney damage and reproductive effects, but says there is inadequate evidence of cancer.

1996 — Monsanto begins marketing “Roundup Ready” seeds that are resistant to glyphosate, urging farmers to use more of its products on these plants without fear of damaging the crops as weeds begin to become glyphosate resistant.

1996 — Monsanto is sued by the New York Attorney General for false and misleading advertising for claims that Roundup is “safer than table salt” and “practically non-toxic.” The company agrees later that year to stop using certain advertising phrases that imply that it is safe, non-toxic, or harmless in New York.

2009 — France’s highest court determines that Monsanto lied about Roundup safety, affirming a lower court’s judgment that Monsanto’s claims that the herbicide was biodegradeable and “left the soil clean” were false.

2015 — In March, the International Agency for Research on Cancer (IARC), part of WHO, determines that glyphsate is a probable carcinogen linked to the increased risk of non-Hodgkin lymphoma, multiple myeloma and other lymphatic cancers.

Roundup Cancer Attorneys

Over the past year, rather than issuing a Roundup recall or taking steps to ensure that farm works, landscapers and others working with the weedkiller are protected against exposure to glyphosate, Monsanto has chosen to essentially “double down” on their marketing and is still attempting to argue that there is no link between cancer and Roundup exposure.

The attorneys at Saiontz & Kirk, P.A. provide free consultations and claims evaluations for individuals and families throughout the United States to determine if financial compensation may be available as a result of a cancer diagnosis following Roundup exposure.

All Roundup cases are reviewed by our law firm on a contingency fee basis, which means that there are no out of pocket costs to hire a lawyer and we receive no attorney fees or expenses unless a recovery is obtained.

CONTACT OUR ROUNDUP LAWYERS ABOUT A CANCER DIAGNOSIS